Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 95
Filtrar
1.
J Bioenerg Biomembr ; 53(5): 585-595, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-34327565

RESUMO

Chronic kidney disease (CKD) remains a major health threat worldwide which is associated with elevated blood level of dimethylamine (DMA) and unbalanced platelet functions. Dimethylamine, a simple aliphatic amine, is abundantly found in human urine as well as other body fluids like plasma. However, the relation between dimethylamine and platelet activation is unclear. This study aims to unravel the mechanism of DMA and platelet function in chronic kidney disease. Through in vitro platelet characterization assay and in vivo CKD mouse model, the level of DMA, platelet activity and renal function were assessed by established methods. PKCδ and its downstream kinase MEK1/2 were examined by immunoblotting analysis of human platelet extract. Rescue experiments with PKCδ inhibitor or choline deficient diet were also conducted. DMA level in plasma of mouse CKD model was elevated along with enhanced platelet activation and comprised renal function. DMA can activate platelet in vitro and in vivo. Inhibition of PKCδ could antagonize the effect of DMA on platelet activation. When choline as the dietary source of DMA was deprived from CKD mouse, the level DMA was reduced and platelet activation was attenuated. Our results demonstrate that dimethylamine could enhance platelet activation in CKD model, potentially through activation of PKCδ.


Assuntos
Plaquetas/efeitos dos fármacos , Dimetilaminas/uso terapêutico , Insuficiência Renal Crônica/tratamento farmacológico , Animais , Dimetilaminas/farmacologia , Modelos Animais de Doenças , Humanos , Masculino , Camundongos , Regulação para Cima
2.
Int Wound J ; 14(1): 79-84, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26712337

RESUMO

For proper wound healing, control of bacteria or bacterial infections is of major importance. While caring for a wound, dressing material plays a key role as bacteria can live in the bandage and keep re-infecting the wound. They do this by forming biofilms in the bandage, which slough off planktonic bacteria and overwhelm the host defense. It is thus necessary to develop a wound dressing that will inhibit bacterial growth. This study examines the effectiveness of a polyurethane foam wound dressing bound with polydiallyl-dimethylammonium chloride (pDADMAC) to inhibit the growth of bacteria in a wound on the back of a mouse. This technology does not allow pDADMAC to leach away from the dressing into the wound, thereby preventing cytotoxic effects. Staphylococcus aureus, Pseudomonas aeruginosa and Acinetobacter baumannii were chosen for the study to infect the wounds. S. aureus and P. aeruginosa are important pathogens in wound infections, while A. baumannii was selected because of its ability to acquire or upregulate antibiotic drug resistance determinants. In addition, two different isolates of methicillin-resistant S. aureus (MRSA) were tested. All the bacteria were measured in the wound dressing and in the wound tissue under the dressing. Using colony-forming unit (CFU) assays, over six logs of inhibition (100%) were found for all the bacterial strains using pDADMAC-treated wound dressing when compared with control-untreated dressing. The CFU assay results obtained with the tissues were significant as there were 4-5 logs of reduction (100%) of the test organism in the tissue of the pDADMAC-covered wound versus that of the control dressing-covered wound. As the pDADMAC cannot leave the dressing (like other antimicrobials), this would imply that the dressing acts as a reservoir for free bacteria from a biofilm and plays a significant role in the development of a wound infection.


Assuntos
Infecções Bacterianas/terapia , Biofilmes/efeitos dos fármacos , Dimetilaminas/uso terapêutico , Curativos Oclusivos , Cicatrização/fisiologia , Infecção dos Ferimentos/terapia , Ferimentos e Lesões/terapia , Animais , Modelos Animais de Doenças , Camundongos , Uretana , Infecção dos Ferimentos/microbiologia
3.
Eur Spine J ; 26(3): 884-893, 2017 03.
Artigo em Inglês | MEDLINE | ID: mdl-28004245

RESUMO

OBJECTIVES: To explore the effect of citric acid (CA)-1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)/N-hydroxysuccinimide (NHS) collagen gel on repairing annular defects. METHODS: Type I collagen was extracted from the rat-tail tendon and crosslinked with CA at different mass ratio using EDC and NHS as crosslinking reagents to prepare four kinds of collagen gels. Forty-eight adult SD rats were divided into first sham group (n = 8), second group (n = 10) which was punctured and injected with CA-EDC/NHS collagen gel, third group (n = 10) which was punctured and injected with CA-EDC/NHS collagen gel, fourth group (n = 10) which was punctured and injected with EDC/NHS collagen gel, and fifth group (n = 10) which was punctured and untreated. X-ray images and magnetic resonance imaging images were obtained before puncture and at the 1st, 2nd, and 4th week after puncture. At each time point, disc height index (%DHI), voxel count and modified MRI Pfirrmann grading were collected and analyzed. All animals were killed at the 4th week to study the morphology. RESULTS: The discs in the second group showed only slight degeneration compared with the healthy discs, and the results of %DHI (average 79%), voxel count (average 126.9), Pfirrmann grading (average grade 1.3) and morphology in the second group indicated less degeneration tendency compared with the other three puncture groups at the 4th week (P < 0.05). The annular fibrosus was partially repaired by the collagen gels that bridged the defects. CONCLUSIONS: CA-EDC/NHS collagen gel is capable of repairing annular defects induced by needle puncture, which may be closely related to the dose of CA.


Assuntos
Anel Fibroso/lesões , Carbodi-Imidas/uso terapêutico , Ácido Cítrico/uso terapêutico , Colágeno Tipo I/uso terapêutico , Reagentes de Ligações Cruzadas/uso terapêutico , Dimetilaminas/uso terapêutico , Agulhas , Punções/efeitos adversos , Ruptura/tratamento farmacológico , Succinimidas/uso terapêutico , Animais , Anel Fibroso/diagnóstico por imagem , Anel Fibroso/patologia , Anticoagulantes/uso terapêutico , Géis/uso terapêutico , Imageamento por Ressonância Magnética , Masculino , Ratos , Ratos Sprague-Dawley , Ruptura/etiologia
4.
Neurobiol Aging ; 31(10): 1690-9, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19022536

RESUMO

Alzheimer's disease (AD) is characterized by depositions of beta-amyloid (A beta) aggregates as amyloid in the brain. To facilitate diagnosis of AD by radioligand imaging, several highly specific small-molecule amyloid ligands have been developed. Because amyloid ligands display excellent pharmacokinetics properties and brain bioavailability, and because we have previously shown that some amyloid ligands bind the highly neurotoxic A beta oligomers (A beta O) with high affinities, they may also be valuable candidates for anti-A beta therapies. Here we identified two fluorene compounds from libraries of amyloid ligands, initially based on their ability to block cell death secondary to intracellular A beta O. We found that the lead fluorenes were able to reduce the amyloid burden including the levels of A beta O in cultured neurons and in 5xFAD mice. To explain these in vitro and in vivo effects, we found that the lead fluorenes bind and destabilize A beta O as shown by electron paramagnetic resonance spectroscopy studies, and block the harmful A beta O-synapse interaction. These fluorenes and future derivatives, therefore, have a potential use in AD therapy and research.


Assuntos
Doença de Alzheimer/diagnóstico , Doença de Alzheimer/tratamento farmacológico , Precursor de Proteína beta-Amiloide/análise , Fluorenos , Doença de Alzheimer/metabolismo , Amiloide/análise , Precursor de Proteína beta-Amiloide/metabolismo , Animais , Encéfalo/metabolismo , Células Cultivadas , Dimetilaminas/química , Dimetilaminas/uso terapêutico , Fluorenos/química , Fluorenos/uso terapêutico , Humanos , Camundongos , Camundongos Transgênicos , Conformação Proteica
5.
In Vivo ; 5(2): 101-5, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1768776

RESUMO

Pretreatment with N,N-dimethylaminoethyl (DMAE) paramylon significantly protected mice from infection by various microorganisms. When mouse peritoneal macrophages were cultured with DMAE-paramylon, they showed morphological change (spreading) and elevated NBT-reducing activity. Macrophages prepared from DMAE-paramylon-treated mice had higher NBT-reducing activity than those from control mice. On the other hand, carboxymethyl paramylon and paramylon sulfate, which did not induce appreciable antimicrobial activity, failed to stimulate macrophage functions. The data suggest a significant role of macrophages in antimicrobial activity induction by cationized glucans.


Assuntos
Anti-Infecciosos/uso terapêutico , Infecções Bacterianas/prevenção & controle , Candidíase/prevenção & controle , Dimetilaminas/uso terapêutico , Glucanos/uso terapêutico , Macrófagos/fisiologia , Animais , Infecções Bacterianas/fisiopatologia , Candidíase/fisiopatologia , Células Cultivadas , Feminino , Macrófagos/citologia , Macrófagos/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos ICR
6.
J Med Chem ; 33(7): 2028-32, 1990 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-1972965

RESUMO

A series of N-[2-(dimethylamino)ethyl]-4-aryl-1-piperazinecarboxamides was synthesized and evaluated for antiallergy activity. Several derivatives had activity in the passive foot anaphylaxis (PFA) assay, an IgE-mediated model useful in the detection of compounds possessing antiallergic activity, but no derivative tested had activity at 10 mg/kg in the guinea pig anaphylaxis (GPA) assay. One analogue, N-[2-(dimethylamino)ethyl]-4-(4-fluorophenyl)-1-piperazinecarboxamide , had an IC50 = 310 nM for inhibition of tritiated mepyramine binding to H1 histaminic receptors isolated from guinea pig cerebral cortex.


Assuntos
Dimetilaminas/síntese química , Antagonistas dos Receptores Histamínicos H1/síntese química , Piperazinas/síntese química , Anafilaxia , Animais , Dimetilaminas/uso terapêutico , Modelos Animais de Doenças , Cobaias , Imunoglobulina E , Indicadores e Reagentes , Estrutura Molecular , Piperazinas/uso terapêutico , Relação Estrutura-Atividade , Teofilina/uso terapêutico
7.
Pharmazie ; 44(8): 560-2, 1989 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2594829

RESUMO

5-Dimethylamino-1-phenyl-1-penten-3-one hydrochloride (1a) has high inhibiting properties in mitochondria isolated from mice liver. Substitution at the 4-methylene group of 1a by different alkyl substituents lead to compounds with wide variation in respiration-inhibiting properties. No correlations were found between either the Charton steric parameter (v), Taft inductive value (f*) or fragmental constant (f) of the substituents at position 4 of the Mannich bases with inhibition of respiration. However the biological results suggested two receptor sites were present in the mitochondria which may interact with the Mannich bases namely a common receptor for all compounds and in addition a narrow hydrophobic binding area which can accommodate a n-butyl or higher alkyl groups which are present in some of the compounds.


Assuntos
Compostos de Benzil/farmacologia , Dimetilaminas/farmacologia , Cetonas/farmacologia , Mitocôndrias Hepáticas/metabolismo , Consumo de Oxigênio/efeitos dos fármacos , Pentanonas/farmacologia , Animais , Compostos de Benzil/uso terapêutico , Cromatografia em Camada Fina , Dimetilaminas/uso terapêutico , Técnicas In Vitro , Leucemia P388/tratamento farmacológico , Espectroscopia de Ressonância Magnética , Masculino , Camundongos , Mitocôndrias Hepáticas/efeitos dos fármacos , Pentanonas/uso terapêutico , Relação Estrutura-Atividade
12.
Cancer Res ; 35(4): 1099-102, 1975 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-1116144

RESUMO

Hexamethylmelamine is known to be effective in humans in the treatment of certain malignant tumors, especially bronchial carcinoma. It is, however, quite inactive against a number of animal tumors, making difficult a study of its mechanism of action in experimental systems. In a reexamination of the effects of hexamethylmelamine, two tumors were found to be very sensitive, namely, a mouse plasma cell tumor (PC6) and a human bronchial carcinoma (P246) growing in immune deprived mice. Both tumors undergo a significant and almost complete regression, even when well established, and hence may serve as model systems for the study of the mechanism of action of hexamethylmelamine.


Assuntos
Antineoplásicos/uso terapêutico , Neoplasias Pulmonares/tratamento farmacológico , Plasmocitoma/tratamento farmacológico , Triazinas/uso terapêutico , Animais , Neoplasias Brônquicas/tratamento farmacológico , Dimetilaminas/uso terapêutico , Humanos , Terapia de Imunossupressão , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos CBA , Modelos Biológicos , Transplante de Neoplasias , Neoplasias Experimentais/tratamento farmacológico , Transplante Heterólogo
13.
Dtsch Med Wochenschr ; 100(9): 427-9, 1975 Feb 28.
Artigo em Alemão | MEDLINE | ID: mdl-234840

RESUMO

Bencyclan (Fludilat), used therapeutically as a vasodilator drug, exerts a distinct negative inotropic and chronotropic action on myocardium, in contrast to papaverine. It prolongs the functional refractory period in the isolated heart preparation. In isolated myocardial mitochondria it decreases the velocity of oxidative phosphorylation and the rate of calcium uptake. These results indicate that heart function should be checked if bencyclan is applied at high dosage, especially if other cardio-depressive substances such as narcotics, antidepressive and antiarrhythmic agents as well as beta-adrenergic blockers are used at the same time. On the other hand, the results suggest that bencyclan should be tested for possible use in the treatment of ischaemic heart disease as well as ventricular and supraventricular tachycardia.


Assuntos
Cicloeptanos/efeitos adversos , Coração/efeitos dos fármacos , Vasodilatadores/efeitos adversos , Antagonistas Adrenérgicos beta/farmacologia , Compostos de Benzil/efeitos adversos , Compostos de Benzil/uso terapêutico , Cálcio/metabolismo , Cicloeptanos/uso terapêutico , Dimetilaminas/efeitos adversos , Dimetilaminas/uso terapêutico , Sinergismo Farmacológico , Mitocôndrias Musculares/efeitos dos fármacos , Miocárdio/metabolismo , Taquicardia/tratamento farmacológico , Fatores de Tempo
16.
J Infect Dis ; 131(1): 11-6, 1975 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-162922

RESUMO

Three hundred four animals were used for the systematic evaluation of the in vivo efficacy of 5-iodo-2'-deoxyuridine (IUDR), cytosire arabinoside, 9-beta-arabinofuranosyladenine, and isoprinosine in the therapy of herpes simplex encephalitis in an adult rat model. Type 1 herpes simplex virus was inoculated intracerabrally, and drug was administered by the intraperitoneal route. All experiments included tests for toxicity and viral controls, Eight sets of experiments were used for evaluation of ttherapy with IUDR; the inoculum ranged from 64 to 2,000 TCID50, dose of drug from 0.1 mg/g to 1.0 mg/g per day, and duration of therapy from one to five days. There was no significant improvement in the number of animals surviving or in the survival time when the viral controls were compared with mice in treated groups. A slight trend toward increased survival time and decreased titer of virus in the brains of animals treated with IUDR was noted in the group that received the largest dose. Three or four sets of experiments were used to evaluate each of the other three antiviral drugs. Results were similar to those reported for IUDR. These results indicate a need for further studies, including investigations of the pharmacology and toxicity of these antiviral agents, to establish more clearly the dosages of drug that are therapeutic, those that are toxic, and ratios of these dosages.


Assuntos
Antivirais/uso terapêutico , Modelos Animais de Doenças , Encefalite/tratamento farmacológico , Herpes Simples/tratamento farmacológico , Acetanilidas/análogos & derivados , Acetanilidas/uso terapêutico , Adenina/análogos & derivados , Adenina/uso terapêutico , Animais , Arabinose/uso terapêutico , Encéfalo/patologia , Linhagem Celular , Técnicas de Cultura , Citarabina/administração & dosagem , Citarabina/uso terapêutico , Dimetilaminas/uso terapêutico , Avaliação de Medicamentos , Encefalite/patologia , Herpes Simples/mortalidade , Herpes Simples/patologia , Idoxuridina/administração & dosagem , Idoxuridina/uso terapêutico , Inosina/análogos & derivados , Inosina/uso terapêutico , Rim/patologia , Pulmão/embriologia , Nucleosídeos/uso terapêutico , Coelhos , Ratos , Simplexvirus
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...